Search research articles
Contact Us
Filters
Showing results (31-40 of 124) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Psychiatry
|
March 21, 1998
Valproate monotherapy in an SRI-intolerant OCD patient
G Corá-Locatelli, B D Greenberg, J D Martin, et al.
Journal of Personality Disorders
|
January 14, 2000
Role of the serotonin transporter gene in temperament and character
D H Hamer, B D Greenberg, S Z Sabol, et al.
Neuromuscular Disorders : NMD
|
September 1, 1993
The influence of denervation on beta-amyloid protein precursor and alpha 1-antichymotrypsin in mouse skeletal muscle
M Akaaboune, J Ma, B W Festoff, et al.
Psychiatric Genetics
|
May 21, 1999
Non-linear association between the serotonin transporter promoter polymorphism and neuroticism: a caution against using extreme samples to identify quantitative trait loci
L A Sirota, B D Greenberg, D L Murphy, et al.
Journal of Neurobiology
|
May 1, 1994
Neurotrophic regulation of mouse muscle beta-amyloid protein precursor and alpha 1-antichymotrypsin as revealed by axotomy
M Akaaboune, J Ma, B W Festoff, et al.
Psychopharmacology
|
May 18, 1999
Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder
J Benjamin, M Geraci, U McCann, et al.
Biological Psychiatry
|
September 7, 2001
Motor cortex excitability correlates with an anxiety-related personality trait
E M Wassermann, B D Greenberg, M B Nguyen, et al.
The Journal of Clinical Psychiatry
|
April 16, 1998
Rebound psychiatric and physical symptoms after gabapentin discontinuation
G Corá-Locatelli, B D Greenberg, J D Martin, et al.
The Journal of Clinical Psychiatry
|
August 24, 1999
Open trial of flutamide for treatment of obsessive-compulsive disorder
M Altemus, B D Greenberg, D Keuler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1996
Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls
D Michelson, M Altemus, E Galliven, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 124) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Psychiatry
|
March 21, 1998
Valproate monotherapy in an SRI-intolerant OCD patient
G Corá-Locatelli, B D Greenberg, J D Martin, et al.
Journal of Personality Disorders
|
January 14, 2000
Role of the serotonin transporter gene in temperament and character
D H Hamer, B D Greenberg, S Z Sabol, et al.
Neuromuscular Disorders : NMD
|
September 1, 1993
The influence of denervation on beta-amyloid protein precursor and alpha 1-antichymotrypsin in mouse skeletal muscle
M Akaaboune, J Ma, B W Festoff, et al.
Psychiatric Genetics
|
May 21, 1999
Non-linear association between the serotonin transporter promoter polymorphism and neuroticism: a caution against using extreme samples to identify quantitative trait loci
L A Sirota, B D Greenberg, D L Murphy, et al.
Journal of Neurobiology
|
May 1, 1994
Neurotrophic regulation of mouse muscle beta-amyloid protein precursor and alpha 1-antichymotrypsin as revealed by axotomy
M Akaaboune, J Ma, B W Festoff, et al.
Psychopharmacology
|
May 18, 1999
Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder
J Benjamin, M Geraci, U McCann, et al.
Biological Psychiatry
|
September 7, 2001
Motor cortex excitability correlates with an anxiety-related personality trait
E M Wassermann, B D Greenberg, M B Nguyen, et al.
The Journal of Clinical Psychiatry
|
April 16, 1998
Rebound psychiatric and physical symptoms after gabapentin discontinuation
G Corá-Locatelli, B D Greenberg, J D Martin, et al.
The Journal of Clinical Psychiatry
|
August 24, 1999
Open trial of flutamide for treatment of obsessive-compulsive disorder
M Altemus, B D Greenberg, D Keuler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1996
Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls
D Michelson, M Altemus, E Galliven, et al.
Page
of 13